[1]蒋淑莲,谭善忠,文 剑.柴芍六君汤治疗慢性乙型肝炎肝纤维化疗效及对患者血清Treg/Th17的影响[J].陕西中医,2021,(9):1229-1232.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.020]
　JIANG Shulian,TAN Shanzhong,WEN Jian.Therapeutic effect of Chaishao Liujun decoction on hepatic fibrosis in chronic hepatitis B and effect on serum Treg/Th17[J].,2021,(9):1229-1232.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.020]
点击复制

柴芍六君汤治疗慢性乙型肝炎肝纤维化疗效及对患者血清Treg/Th17的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1229-1232
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Therapeutic effect of Chaishao Liujun decoction on hepatic fibrosis in chronic hepatitis B and effect on serum Treg/Th17
作者:
蒋淑莲1; 谭善忠1; 文 剑2
(1.南京中医药大学附属南京医院中西医结合科,江苏 南京 210023; 2.桂林医学院附属医院,广西 桂林 541001)
Author(s):
JIANG Shulian; TAN Shanzhong; WEN Jian
(Department of Integrated Traditional Chinese and Western Medicine,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210000,China)
关键词:
慢性乙型肝炎;  肝纤维化;  柴芍六君汤;  调节性T淋巴细胞;  辅助性T淋巴细胞17;  免疫功能
Keywords:
Chronic hepatitis B;  Hepatic fibrosis;  Chaishao Liujun decoction;  Regulatory T cells;  Helper T lymphocyte 17;  Immune function
分类号:
R 512.6
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.020
文献标志码:
A
摘要:
目的:探讨柴芍六君汤治疗慢性乙型肝炎肝纤维化疗效及对患者血清Treg/Th17的影响。方法:90例慢性乙型肝炎肝纤维化肝郁脾虚证患者随机分为两组,对照组给予恩替卡韦治疗,治疗组在对照组基础上加用柴芍六君汤,疗程24周。比较两组疗效、中医证候积分、肝功能指标[丙氨酸氨基转移酶(ALT)、γ-谷氨酸酰基转移酶(GGT)及天门冬氨酸氨基转移酶(AST)]、肝纤维化指标[层黏蛋白(LN)、Ⅲ型前胶原(PC Ⅲ)、Ⅳ型胶原(Ⅳ-C)和透明质酸(HA)]、免疫功能(CD3+、CD4+、CD8+、CD4+/ CD8+)及Treg/Th17水平指标。结果:治疗组总有效率93.33%,对照组75.56%,组间比较差异有统计学意义(P<0.05)。治疗后,治疗组腹胀、胁肋疼痛、便溏、倦怠乏力及纳食减少证候评分低于对照组(均P<0.05)。治疗后治疗组血清ALT、GGT、AST、PC Ⅲ、Ⅳ-C、LN、HA、CD8+、Th17细胞、Treg细胞及Treg/Th17低于对照组(均P<0.05)。治疗后治疗组血清CD3+、CD4+、CD4+/ CD8+水平高于对照组(均P<0.05)。结论:柴芍六君汤治疗慢性乙型肝炎肝纤维化疗效较好,可改善患者肝功能和免疫功能,抑制肝纤维化,调节Treg/Th17平衡。
Abstract:
Objective:To explore curative effect of Chaishao Liujun decoction in treatment of hepatic fibrosis in chronic hepatitis B and its influence on serum Treg/Th17.Methods:90 patients with hepatic fibrosis in chronic hepatitis B of Ganyu Pixu syndrome were randomly divided into two groups.The control group was treated with entecavir,and the treatment group treated with Chaishao Liujun decoction for 24 weeks.Therapeutic effects,TCM syndrome scores,liver function indexes [alanine aminotransferase(ALT),γ-glutamate acyl transfer Enzymes(GGT)and aspartate aminotransferase(AST),Index of liver fibrosis[laminin(LN),type Ⅲ procollagen(PC Ⅲ),type Ⅳ collagen(Ⅳ-C)and hyaluronic acid(HA)],immune function [CD3+,CD4+,CD8+and CD4+/CD8+]and Th17/Treg level indicators.Results:The total effective rate was 93.33% in the treatment group and 75.56% in the control group,difference statistically significant(P<0.05).After treatment,symptom scores of Fuzhang,Xielei Tengtong,Biantang,Juandai Fali,Nashi Jianshao in the treatment group were lower than those in the control group(all P<0.05).Serum ALT,GGT,AST,PCⅢ,Ⅳ-C,LN,HA,CD8+,Th17 cells,Treg cells and Treg/Th17 were significantly lower than those in the control group(all P<0.05).After treatment,serum CD3+,CD4+,CD4+/CD8+ levels in the treatment group were significantly higher than those in the control group(all P<0.05).Conclusion:Chaishao Liujun decoction is effective in treating hepatic fibrosis in chronic hepatitis B.It can significantly improve liver function and immune function,inhibit liver fibrosis,and regulate ratio of Treg/Th17.

参考文献/References:

[1] 田水林,施 琳,施卫兵.逍遥散联合恩替卡韦治疗肝郁脾虚型慢性乙型肝炎疗效研究[J].陕西中医,2020,41(6):754-757.
[2] 刘小莹,郑宏波,王山军,等.恩替卡韦单药方案维持对初始行拉米夫定+阿德福韦酯方案治疗慢性乙型肝炎及慢性乙型肝炎后肝硬化疗效影响[J].陕西医学杂志,2020,49(4):502-505.
[3] 陈莉熔,区增冠,陈秀编,等.柴芍六君子汤加减配合穴位贴敷治疗慢性乙型肝炎转氨酶轻度升高的效果观察[J].中国现代药物应用,2019,13(9):138-139.
[4] 王贵强,王福生,庄 辉,等.慢性乙型肝炎防治指南[J].肝脏,2019,24(12):6-27.
[5] 中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南[J].中华肝脏病杂志,2019,27(7):494-504.
[6] 中华中医药学会肝胆病专业委员会,中国民族医药学会肝病专业委员会,王灵台,等.慢性乙型肝炎中医诊疗指南[J].临床肝胆病杂志,2018,34(12):39-44.
[7] 中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5):327-328.
[8] 康燕能,王 敏,林辉瑶,等.慢性乙型肝炎中医证型与客观指标相关性研究概况[J].陕西中医,2018,39(7):983-985.
[9] 陈 龙,赵超群,张 华,等.慢性乙型肝炎血瘀病机与肝脏纤维组织沉积及血管新生病理变化关系研究[J].上海中医药杂志,2019,53(3):9-14.
[10] 张明发,沈雅琴.氧化苦参碱治疗慢性乙型肝炎的临床评价研究进展[J].药物评价研究,2019,42(9):188-197.
[11] 白正学.把《内经》五郁治则应用于肾脏病的临床体会[J].环球中医药,2020,13(2):310-313.
[12] 陈寅萤,王 忠,南景一,等.中医药治疗慢性乙型肝炎的研究进展[J].世界中西医结合杂志,2020,15(4):197-202.
[13] 崔 敬,庄国柱,姜爱华,等.柴芍六君子汤加味联合阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎(肝郁脾虚型)临床观察[J].辽宁中医药大学学报,2020,22(1):190-193.
[14] 丁少华,李桂贤,陈国忠,等.李桂贤运用柴芍六君汤经验总结[J].辽宁中医杂志,2019,46(3):476-479.
[15] 刘先姜,王 雅,王 娜,等.柴芍六君子汤加减治疗非酒精性脂肪性肝炎肝郁脾虚证临床研究[J].中国中医药信息杂志,2021,28(1):118-122.
[16] 朱义玲,甘建和,赵卫峰,等.慢性乙型肝炎患者外周血调节性T细胞,Th17细胞的水平及与乙肝表面抗原滴度的相关性[J].中国感染与化疗杂志,2020,20(5):42-46.
[17] 孙 俊,王宏志,汪 毅,等.柴芍六君子汤合半夏泻心汤加减治疗肝郁脾虚证功能性消化不良的临床效果及对患者NO、AchE、GAS、5-HT含量的影响[J].环球中医药,2018,11(3):444-447.
[18] 柏文婕,石清兰,毛德文,等.柴芍六君汤对慢性乙型肝炎肝郁脾虚证患者肝纤维化相关指标改善作用以及血清Treg/Th17比率变化的影响[J].中国中医基础医学杂志,2019,25(8):97-100,108.
[19] 许 娟,张文艳,杨 澍.柴芍六君子汤加减对慢性乙型肝炎肝纤维化患者肝纤化指标及Th1、Th2细胞因子谱的影响[J].中医药导报,2017,23(13):113-115.
[20] 张意兰,冯军安,韩际奥.祛毒退黄汤结肠滴注给药对慢性乙型肝炎肠源性内毒素血症外周血Th17/Treg细胞因子和肝功能的影响[J].陕西中医,2019,40(1):55-57.

相似文献/References:

[1]张意兰,冯军安,韩际奥.祛毒退黄汤结肠滴注给药对慢性乙型肝炎肠源性内毒素血症、外周血Th17/Treg细胞因子和肝功能的影响*[J].陕西中医,2019,(1):55.
　ZHANG Yilan,FENG Junan,HAN Jiao..Effect of sputum and phlegmremoving broth in colonic endotoxemia, peripheral blood Th17/Treg cytokines and liver function in patients with chronic he patitis B[J].,2019,(9):55.
[2]杨建华,屈芙蓉,杨建军,等.十味诃子汤散联合恩替卡韦分散片治疗慢性乙型肝炎合并非酒精性脂肪性肝炎疗效研究*[J].陕西中医,2019,(11):1507.
　YANG Jianhua,QU Furong,YANG Jianjun,et al.Observation on the therapeutic effect of Shiwei Hezitang powder combined with entecavir dispersible tablets in treating chronic hepatitis B complicated with nonalcoholic steatohepatitis[J].,2019,(9):1507.
[3]田水林,施 琳,施卫兵△.逍遥散联合恩替卡韦治疗肝郁脾虚型慢性乙型肝炎疗效研究*[J].陕西中医,2020,(6):754.[doi:DOI:10.3969/j.issn.10007369.2020.06.015]
　TIAN Shuilin,SHI Lin,SHI Weibing..Study on effect of Xiaoyao powder combined with entecavir on patients with chronic hepatitis B of Ganyu Pixu type[J].,2020,(9):754.[doi:DOI:10.3969/j.issn.10007369.2020.06.015]
[4]雷 玲,闵 珺,刘 锋,等.黄芪对肝纤维化大鼠肝损伤保护作用及机制研究*[J].陕西中医,2020,(9):1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.004]
　LEI Ling,MIN Jun,LIU Feng,et al.Study on protective effects and mechanism of astragalus on hepatic injury of rats with hepatic fibrosis[J].,2020,(9):1192.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.004]
[5]蔡 菁,葛亚强,许丽娟,等.蒿属香豆素对MCD饮食诱导的非酒精性脂肪性肝纤维化小鼠保护性作用的研究[J].陕西中医,2021,(11):1511.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.004]
　CAI Jing,GE Yaqiang,XU Lijuan,et al.Protective effect of scoparone on MCD diet induced liver fibrosis in mice[J].,2021,(9):1511.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.004]
[6]吴必建,章一凡.猪苓汤加味联合多烯磷脂酰胆碱治疗早期肝硬化疗效研究[J].陕西中医,2021,(12):1706.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.013]
[7]苟 芳,张红军,王 洁,等.黄连解毒汤通过抑制TGF-β信号通路减轻2型糖尿病大鼠肝脂肪变性和纤维化研究[J].陕西中医,2022,(2):170.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.007]
　GOU Fang,ZHANG Hongjun,WANG Jie,et al.Huanglian Jiedu decoction alleviates hepatic steatosis and fibrosis in type 2 diabetic rats through activation of TGF - β signaling pathway[J].,2022,(9):170.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.007]
[8]孙素红,周晓玲,李泽鹏,等.柴胡当归散加减联合穴位注射丹参注射液治疗乙肝肝纤维化临床观察[J].陕西中医,2024,(4):477.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.009]
　SUN Suhong,ZHOU Xiaoling,LI Zepeng,et al.Clinical observation on the treatment of liver fibrosis in hepatitis B with modified Chaihu Danggui powder combined with acupoint injection of Danshen injection[J].,2024,(9):477.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.009]
[9]谢 旭,李国焕,贾文燕,等.参芪软肝汤配合抗病毒药物治疗肝硬化临床研究[J].陕西中医,2024,(6):771.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.010]
　XIE Xu,LI Guohuan,JIA Wenyan,et al.Shenqi Ruangan decoction combined with antiviral drugs in the treatment of liver cirrhosis[J].,2024,(9):771.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.010]
[10]魏涛华,杨文明,宋宇琪,等.名中医杨文明治疗Wilson病患者肝纤维化之肝豆扶木汤理法方药体系探析[J].陕西中医,2025,46(4):527.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.020]

备注/Memo

备注/Memo:
基金项目:广西壮族自治区自然科学基金资助项目(2017GXNSFAA198112)
更新日期/Last Update: 2021-09-10